当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析

安图生物

(603658)

  

流通市值:196.63亿  总市值:196.63亿
流通股本:5.71亿   总股本:5.71亿

安图生物(603658)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.39亿元,每股收益0.41元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益925521.84万元,未分配利润496768.60万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1224221.82万元,负债298699.98万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入992,202,191.514,226,413,277.243,127,156,171.62,060,307,179.95
营业总成本758,254,185.723,171,017,904.492,294,860,260.371,506,453,270.45
其他经营收益
营业利润262,754,207.91,217,929,013.35952,196,649.69636,811,439.57
利润总额261,986,759.651,222,766,392.56959,174,314638,845,435.17
净利润239,137,278.561,086,384,222.05872,725,088.32578,036,989.75
每股收益
其他综合收益-160,461.9-195,065.28-84,048.63-8,422.01
综合收益总额238,976,816.661,086,189,156.77872,641,039.69578,028,567.74
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计6,093,324,729.446,308,275,297.165,880,262,392.785,930,679,670.16
非流动资产:
非流动资产合计6,148,893,448.975,981,449,834.545,846,682,436.925,714,704,290.29
资产总计12,242,218,178.4112,289,725,131.711,726,944,829.711,645,383,960.45
流动负债:
流动负债合计2,278,136,483.342,629,301,146.12,280,644,264.582,531,681,037.53
非流动负债:
非流动负债合计708,863,302.82644,182,410.01600,755,206.63562,770,036.38
负债合计2,986,999,786.163,273,483,556.112,881,399,471.213,094,451,073.91
所有者权益(或股东权益):
归属于母公司股东权益合计9,162,441,066.518,926,154,166.038,746,504,579.18,458,066,259.73
股东权益合计9,255,218,392.259,016,241,575.598,845,545,358.498,550,932,886.54
负债和股东权益合计12,242,218,178.4112,289,725,131.711,726,944,829.711,645,383,960.45
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,230,595,128.874,919,236,784.493,581,762,531.262,320,053,939.83
经营活动现金流出小计1,084,022,628.373,577,555,021.742,736,340,717.871,909,870,014.48
经营活动产生的现金流量净额146,572,500.51,341,681,762.75845,421,813.39410,183,925.35
投资活动产生的现金流量:
投资活动现金流入小计2,227,823,742.534,980,273,193.854,040,066,091.922,767,973,416.14
投资活动现金流出小计2,058,586,141.465,395,623,707.123,801,634,004.42,465,838,886.17
投资活动产生的现金流量净额169,237,601.07-415,350,513.27238,432,087.52302,134,529.97
筹资活动产生的现金流量:
筹资活动现金流入小计163,850,0002,018,634,905.011,582,459,788.591,295,522,997.74
筹资活动现金流出小计265,857,476.052,814,927,795.442,529,002,548.462,008,806,278.48
筹资活动产生的现金流量净额-102,007,476.05-796,292,890.43-946,542,759.87-713,283,280.74
汇率变动对现金及现金等价物的影响-7,662,969.99774,015.752,418,501.373,246,257.44
现金及现金等价物净增加额206,139,655.53130,812,374.8139,729,642.412,281,432.02
期末现金及现金等价物余额789,010,379.14582,870,723.61591,787,991.22454,339,780.83
补充资料:
现金及现金等价物的净增加额-130,812,374.8-2,281,432.02
最新报告期:2026-05-08
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信证券宋硕,陈竹,张斌斌2.042.302.662026-05-08
光大证券黎一江2.032.402.842026-04-28
中国银河孟熙,程培2.032.342.692026-04-24
中金公司俞波,张琎,陈诗雨2.062.31--2026-04-24
中泰证券祝嘉琦,谢木青2.022.352.732026-04-23
TOP↑